But you — and the Twitter trolls — may have noticed that Jenner’s skin has done a complete 180 recently. At first, she owned her acne; then, she managed to kick it, leading to headlines that are less “just like us” and more like “glowy” and “radiant.” So what changed? The answer: Christie Kidd, dermatology… Read More: Kendall Jenner's Skin Guru Spills The 5 Tips For Clearing… »
FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer Print this page November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer… Read More: FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell… »
A treatment regimen containing ibalizumab (Trogarzo), a monoclonal antibody designed to block HIV, led to substantial viral load reductions in a majority of highly treatment-experienced people with few treatment options left, Dr Zvi Cohen of Theratechnologies reported at the International Congress on Drug Therapy in HIV Infection (HIV Glasgow) on Wednesday. Fifteen out of 40… Read More: Prolonged HIV suppression is possible using ibalizumab, analysis of highly… »
The National Institutes of Health is making new investments into the BRAIN Initiative, which will include new studies of opioids. New funds of $ 220 million to support 200 new research awards have been awarded, bringing total 2018 program support to more than $ 400 million, which is 50 percent more than the amount spent… Read More: NIH boosts BRAIN Initiative funding to expand study into opioids »